Antidote for Acetaminophen Poisoning
Mechanism of Action
Inhibiting liver enzyme activity to prevent the generation of toxic metabolites of acetaminophen known to cause liver damage.
- Received TFDA orphan drug designation.
- SNP-820 is the effective antidote component of SNP-810, and has been approved by TFDA to conduct Phase II clinical trial in patients with acetaminophen poisoning.
- The efficacy is better than the current standard of treatment (N-acetylcysteine).
- The detoxification ingredients are the same as some of the ingredients of SNP-810, which can prove the efficacy of each other.
SNP-820 is medically important even though the market is not big. SINEW has developed SNP-820 as social welfare.